Xu B - Search Results

1

TGFβ Treatment Enhances Glioblastoma Virotherapy by Inhibiting the Innate Immune Response.

Han J, Chen X, Chu J, Xu B, Meisen WH, Chen L, Zhang L, Zhang J, He X, Wang QE, Chiocca EA, Kaur B, Caligiuri MA, Yu J. Han J, et al. Among authors: xu b. Cancer Res. 2015 Dec 15;75(24):5273-82. doi: 10.1158/0008-5472.CAN-15-0894. Epub 2015 Dec 2. Cancer Res. 2015. PMID: 26631269 Free PMC article.

2

BAI1 Orchestrates Macrophage Inflammatory Response to HSV Infection-Implications for Oncolytic Viral Therapy.

Bolyard C, Meisen WH, Banasavadi-Siddegowda Y, Hardcastle J, Yoo JY, Wohleb ES, Wojton J, Yu JG, Dubin S, Khosla M, Xu B, Smith J, Alvarez-Breckenridge C, Pow-Anpongkul P, Pichiorri F, Zhang J, Old M, Zhu D, Van Meir EG, Godbout JP, Caligiuri MA, Yu J, Kaur B. Bolyard C, et al. Among authors: xu b. Clin Cancer Res. 2017 Apr 1;23(7):1809-1819. doi: 10.1158/1078-0432.CCR-16-1818. Epub 2016 Nov 9. Clin Cancer Res. 2017. PMID: 27852701 Free PMC article.

3

An Oncolytic Virus Expressing IL15/IL15Rα Combined with Off-the-Shelf EGFR-CAR NK Cells Targets Glioblastoma.

Ma R, Lu T, Li Z, Teng KY, Mansour AG, Yu M, Tian L, Xu B, Ma S, Zhang J, Barr T, Peng Y, Caligiuri MA, Yu J. Ma R, et al. Among authors: xu b. Cancer Res. 2021 Jul 1;81(13):3635-3648. doi: 10.1158/0008-5472.CAN-21-0035. Epub 2021 May 18. Cancer Res. 2021. PMID: 34006525 Free PMC article.

4

An oncolytic virus expressing a full-length antibody enhances antitumor innate immune response to glioblastoma.

Xu B, Tian L, Chen J, Wang J, Ma R, Dong W, Li A, Zhang J, Antonio Chiocca E, Kaur B, Feng M, Caligiuri MA, Yu J. Xu B, et al. Nat Commun. 2021 Oct 8;12(1):5908. doi: 10.1038/s41467-021-26003-6. Nat Commun. 2021. PMID: 34625564 Free PMC article.

5

The natural product chitosan enhances the anti-tumor activity of natural killer cells by activating dendritic cells.

Li X, Dong W, Nalin AP, Wang Y, Pan P, Xu B, Zhang Y, Tun S, Zhang J, Wang LS, He X, Caligiuri MA, Yu J. Li X, et al. Among authors: xu b. Oncoimmunology. 2018 Mar 13;7(6):e1431085. doi: 10.1080/2162402X.2018.1431085. eCollection 2018. Oncoimmunology. 2018. PMID: 29872557 Free PMC article.

6

An oncolytic herpesvirus expressing E-cadherin improves survival in mouse models of glioblastoma.

Xu B, Ma R, Russell L, Yoo JY, Han J, Cui H, Yi P, Zhang J, Nakashima H, Dai H, Chiocca EA, Kaur B, Caligiuri MA, Yu J. Xu B, et al. Nat Biotechnol. 2018 Nov 26:10.1038/nbt.4302. doi: 10.1038/nbt.4302. Online ahead of print. Nat Biotechnol. 2018. PMID: 30475349 Free PMC article.

7

Targeting Fc Receptor-Mediated Effects and the "Don't Eat Me" Signal with an Oncolytic Virus Expressing an Anti-CD47 Antibody to Treat Metastatic Ovarian Cancer.

Tian L, Xu B, Teng KY, Song M, Zhu Z, Chen Y, Wang J, Zhang J, Feng M, Kaur B, Rodriguez L, Caligiuri MA, Yu J. Tian L, et al. Among authors: xu b. Clin Cancer Res. 2022 Jan 1;28(1):201-214. doi: 10.1158/1078-0432.CCR-21-1248. Epub 2021 Oct 13. Clin Cancer Res. 2022. PMID: 34645647 Free PMC article.

8

Off-the-Shelf Prostate Stem Cell Antigen-Directed Chimeric Antigen Receptor Natural Killer Cell Therapy to Treat Pancreatic Cancer.

Teng KY, Mansour AG, Zhu Z, Li Z, Tian L, Ma S, Xu B, Lu T, Chen H, Hou D, Zhang J, Priceman SJ, Caligiuri MA, Yu J. Teng KY, et al. Among authors: xu b. Gastroenterology. 2022 Apr;162(4):1319-1333. doi: 10.1053/j.gastro.2021.12.281. Epub 2022 Jan 6. Gastroenterology. 2022. PMID: 34999097 Free PMC article.

9

Amendments: Publisher Correction: An oncolytic herpesvirus expressing E-cadherin improves survival in mouse models of glioblastoma.

Xu B, Ma R, Russell L, Yoo JY, Han J, Cui H, Yi P, Zhang J, Nakashima H, Dai H, Chiocca EA, Kaur B, Caligiuri MA, Yu J. Xu B, et al. Nat Biotechnol. 2019 Jan 3;37(1):102. doi: 10.1038/nbt0119-102c. Nat Biotechnol. 2019. PMID: 30605164 No abstract available.

10

Effect of cabazitaxel on macrophages improves CD47-targeted immunotherapy for triple-negative breast cancer.

Cao X, Li B, Chen J, Dang J, Chen S, Gunes EG, Xu B, Tian L, Muend S, Raoof M, Querfeld C, Yu J, Rosen ST, Wang Y, Feng M. Cao X, et al. Among authors: xu b. J Immunother Cancer. 2021 Mar;9(3):e002022. doi: 10.1136/jitc-2020-002022. J Immunother Cancer. 2021. PMID: 33753567 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

16,557 results

Search Page